말초혈액 내 백혈구수와 대사증후군과의 연관성

논문상세정보

' 말초혈액 내 백혈구수와 대사증후군과의 연관성' 의 참고문헌

  • White blood cellcount and the risk of coronary heart diseaseand all-causemortality in elderly men 16
    499 ~ 503 [1996]
  • White blood cellcount and cardiovascular disease 267
    1253 ~ 1256 [1992]
  • White blood cell countand clustered features of metabolic syndrome in Japanesemale office workers 52
    213 ~ 218 [2002]
  • Weight reductionincreases plasma levels of an adipose-derived anti-inflammatoryprotein, adiponectin 86
    3815 ~ 3819 [2001]
  • Tumor necrosis factor-α: a key component of the obesity-diabetes link 43
    1271 ~ 1278 [1994]
  • TheTNF-a gene NcoI polymorphism influences the relationshipamong insulin resistance, percent body fat, and increasedserum leptin levels 46
    1468 ~ 1472 [1997]
  • The white blood cell count: its relationship toplasma insulin and other cardiovascular risk factors inhealthy male individuals 239
    435 ~ 441 [1996]
  • The relationship ofwhite blood cell count to other cardiovascular risk factors 19
    881 ~ 888 [1990]
  • The pathogenesis of atherosclerosis: a perspectivefor the 1990s 362
    801 ~ 809 [1993]
  • The leukocyte count: correlates and relationshipto coronary risk factors 19
    889 ~ 893 [1990]
  • The leukocyecount as a predictor of myocardial infection 290
    1275 ~ 1278 [1974]
  • The fatderivedhormone adiponectin reverses insulin resistance associatedwith both lipoatrophy and obesity 7
    941 ~ 946 [2001]
  • The differential effect of food intake and β-adrenergicstimulation on adipose-derived hormones and cytokines inman 84
    2126 ~ 2133 [1999]
  • Subcutaneous adiposetissue releases interleukin-6, but not tumor necrosis factor-α in vivo 82
    4196 ~ 4200 [1997]
  • Regulation of the acute phase response by cytokines 36
    611 ~ 622 [1993]
  • Proteolytic cleavageproduct of 30-kDa adipocyte complement-related proteinincreases fatty acid oxidation in muscle and causes weightloss in mice 98
    2005 ~ 2010 [2001]
  • Production of C-reactive protein and risk of coronaryevents in stable and unstable angina 349
    462 ~ 466 [1997]
  • Plasma concentrations of a novel,adipose-specific protein, adiponectin, in type 2 diabetic patients 20
    1595 ~ 1599 [2000]
  • Omental and subcutaneousadipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid 83
    847 ~ 850 [1998]
  • Lifetime smoking exposure affectsthe association of C-reactive protein with cardiovasculardisease risk factors and subclinical disease in healthyelderly subjects 17
    2167 ~ 2176 [1997]
  • Leukocytes and the risk of ischemic disease 257
    2318 ~ 2324 [1987]
  • Leukocytecount correlates in middle-aged adults 136
    525 ~ 537 [1992]
  • Leukocyte count, smokingand myocardial infartion 304
    465 ~ 468 [1981]
  • Leukocyte count and fibrinogen are associated with carotidand femoral intima-media thickness in a risk populationfor diabetes 56
    277 ~ 283 [2002]
  • Interleukin-6 as a central mediator of cardiovascularrisk associated with chronic inflammation, smoking,diabetes, and visceral obesity: down-regulation with essentialfatty acids, ethanol and pentoxifylline 52
    465 ~ 477 [1999]
  • In vivo measurements of"apparent viscosity" and microvessel hematocrit in themesentery of the cat 19
    297 ~ 319 [1980]
  • Importance of TNF-α and leptin in obesity and insulin resistance: a hypothesison the impact of physical exercise 4
    77 ~ 94 [1998]
  • Hyperinsulinemia:the key feature of a cardiovascular and metabolicsyndrome 34
    416 ~ 422 [1991]
  • Growth-promoting effects of insulin-likegrowth factor-1 (IGF-1) on hematopoietic cells: overexpressionof introduced IGF-1 receptor abrogates interleukin-3dependency of murine factor-dependent cells by a liganddependentmechanism 78
    921 ~ 929 [1991]
  • Genetic analysis of the IRS: pleiotropic effects ofgenes influencing insulin levels on lipoprotein and obesitymeasures 16
    281 ~ 288 [1996]
  • Fibrinogen, viscosity, andwhite blood cell count are major risk factors for ischemicheart disease 83
    836 ~ 844 [1991]
  • Familial components ofthe multiple metabolic syndrome 40
    963 ~ 970 [1997]
  • Expert Panel on Detection, Evaluation, and Treatment ofHigh Blood Choesterol in Adults. Executive summary of thethird report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatmentof high blood choesterol in adults (Adult TreatmentPanel Ⅲ). 285
    2486 ~ 2497 [2001]
  • Executive summary of the Third Report of the NationalCholesterol Education Program (NCEP) Expert Panel onDetection, Evaluation, and Treatment of Hight Blood Cholesterolin Adults (Adult Treatment Panel III) 285
    2486 ~ 2496 [2001]
  • Chronic subclinical inflammation as partof the insulin resistance syndrome 102
    42 ~ 47 [2000]
  • C-reactiveprotein in healthy subjects: associations with obesity,insulin resistance, and endothelial dysfunction 19
    972 ~ 978 [1999]
  • C-reactive protein,a sensitive marker of inflammation, predicts future risk ofco-ronary heart disease in initially healthy midle agedmen 99
    237 ~ 242 [1999]
  • C reactive protein and its relation to cardiovascular riskfactors: a population based cross sectional study 312
    1061 ~ 1065 [1996]
  • Approach to lipoprotein management in 2001National Cholesterol Guidelines 90 (Suppl)
    11i ~ 21i [2002]
  • Anadipocyte-derived plasma protein, adiponectin adheres toinjured vascular walls 32
    47 ~ 50 [2000]
  • Adipocyte-derived plasma protein,adiponectin, suppresses lipid accumulation and class Ascavenger receptor expression in human monocyte-derivedmacrophages 103
    1057 ~ 1063 [2001]
  • Acute systemic inflammationimpairs endothelium-dependent dilatation in humans 102
    994 ~ 999 [2000]